Researchers have identified three "hotspots" in the United States where progress on reducing death rates from colorectal cancer have lagged, shining a light on areas of the country where efforts to increase screening uptake and promote healthier lifestyles could make a big difference.
Though having a high body mass index is associated with a higher risk for colorectal cancer, patients who are thinner may not do as well after treatment for metastatic colorectal cancer.
PracticeNET offers advice on oncology operations and quality of care.
Thousands of women have made the selfless choice to literally donate a precious piece of themselves by giving a breast tissue sample to the Susan G. Komen Tissue Bank at the Indiana University Melvin and Bren Simon Cancer Center, a unique resource for researchers worldwide.
Patients who participate in the registry contribute to not only helping themselves, but also to providing critical data to help women worldwide make educated decisions.
A single intravenous dose of fosaprepitant dimeglumine was shown to be superior to placebo when either were combined with other anti-vomiting agents for protection against chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
Trend has important implications for cancer care in the United States.
A study looking at the care experiences and possible stressors for Latina women undergoing chemotherapy to treat their breast cancer has found that this patient population feels particular stress related to their family and other interpersonal relationships.
The Prostate Cancer Foundation is throwing a one-two punch to knock out prostate cancer for good with the recent production of a public service announcement featuring boxing legend and five-time heavyweight champion of the world Evander Holyfield.
The Supreme Court's 6-3 ruling preserves tax credits that have allowed millions of Americans to purchase health insurance.
The "What's Your History" campaign is intended to encourage and teach people to be proactive in learning more about their family's history of cancer.
The rise in survivorship has increased chronic pain in the cancer pain population, the treatment of which has many fundamental differences when compared with treatment for acute and terminal cancer pain.
Having been in palliative care since 2006, my face is a familiar one at the cancer center. While it has bought me 12 years so far, and hopefully many more, I'm still trying to navigate a "new normal."
Patient-centered website partners with the FDA for drug safety surveillance.
A twice-per-week, 20-minute, acupuncture-like nerve stimulation treatment may help to relieve the symptoms of radiation-induced xerostomia (dry mouth).
Interactive town meeting will offer the latest information on lung cancer treatment and research.
Nausea and vomiting associated with anticancer therapies continue to be among patients' most troubling symptoms. Findings of a clinical trial found that olanzapine demonstrated comparative benefits in relieving these symptoms.
The number of women deciding to have breast-conserving therapy to treat their early-stage breast cancer has been steadily increasing, but these gains are muted for some women due to such factors as insurance status, income, and travel distance to treatment centers.
Diminished quality of life observed in women during the early survivorship period.
A number of effective strategies exist for addressing hand-foot skin reaction to help ensure patients remain on their treatment with regorafenib (Stivarga).
The lack of comprehensive rehabilitation services is a profound source of unnecessary suffering for survivors.
During cancer treatments, patients are not the only ones who need care.
Nurses find that nature sounds and soothing music are effective.
Early-stage cancer patients who are physically active throughout chemotherapy have a reduced risk of experiencing cognitive impairment known as "chemobrain," and are less likely to have chronic inflammation.
Findings from an analysis of more than 34,000 participants in the Childhood Cancer Survivor Study show that among those who have survived at least 5 years, all-cause mortality at 15 years after diagnosis dropped by half from 12.4% to 6%.
In a phase III trial the immunotherapy nivolumab (Opdivo) improved overall survival and was less toxic than docetaxel in both nonsquamous and squamous non–small cell lung cancer.
ASCO updates clinical guideline screening among patients at high risk for HBV infection or HBV reactivation after chemotherapy.
ASCO's first-ever clinical trial aims to match patients who have run out of treatment options with therapies that are FDA-approved to treat tumors with their genetic variant but for a different type of cancer.
Adding palbociclib (Ibrance) to standard fulvestrant more than doubled progression-free survival in pretreated patients with HR-positive, HER2-negative breast cancer, according to study results presented at the 2015 ASCO Annual Meeting.
A new study reported at the 2015 ASCO Annual Meeting suggests that anastrozole may be better than tamoxifen for many women who choose adjuvant therapy to prevent recurrence after DCIS.